Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 185

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Animal models of drug-induced liver injury

McGill, Mitchell R., Jaeschke, Hartmut · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Abstract

Drug-induced liver injury (DILI) presents unique challenges for consumers, clinicians, and regulators. It is the most common cause of acute liver failure in the US. It is also one of the most common reasons for termination of new drugs during pre-clinical testing and withdrawal of new drugs post-marketing. DILI is generally divided into two forms: intrinsic and idiosyncratic. Many of the challenges with DILI are due in large part to poor understanding of the mechanisms of toxicity. Although useful models of intrinsic DILI are available, they are frequently misused. Modeling idiosyncratic DILI presents greater challenges, but promising new models have recently been developed. The purpose of this manuscript is to provide a critical review of the most popular animal models of DILI, and to discuss the future of DILI research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbadis.2018.08.037

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 127

  1. Lee, 2008, Etiologies of acute liver failure, Semin. Liver Dis., 28, 142, 10.1055/s-2008-1073114 · DOI · Paper page
  2. Davern, 2006, Measurement of serum acetaminophen-protein adducts in patients with acute liver failure, Gastroenterology, 130, 687, 10.1053/j.gastro.2006.01.033 · DOI · Paper page
  3. Ganger, 2018, Acute liver failure study group. Acute liver failure of indeterminate etiology: a comprehensive systematic approach by an expert committee to establish causality, Am. J. Gastroenterol., 10.1038/s41395-018-0160-2 · DOI
  4. James, 2006, Pediatric acute liver failure study group. Detection of acetaminophen protein adducts in children with acute liver failure of indeterminate cause, Pediatrics, 118, e676, 10.1542/peds.2006-0069 · DOI
  5. Issa, 2007, Drug withdrawals in the United States: a systematic review of the evidence and analysis of trends, Curr. Drug Saf., 2, 177, 10.2174/157488607781668855 · DOI
  6. Onakpoya, 2016, Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature, BMC Med., 14
  7. Solotke, 2018, New and incremental FDA black box warnings from 2008 to 2015, Expert Opin. Drug Saf., 17, 117, 10.1080/14740338.2018.1415323 · DOI
  8. Lammert, 2008, Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals, Hepatology, 47, 2003, 10.1002/hep.22272 · DOI · Paper page
  9. Uetrecht, 2001, Prediction of a new drug's potential to cause idiosyncratic reactions, Curr. Opin. Drug Discov. Devel., 4, 55
  10. Walgren, 2005, Role of metabolism in drug-induced idiosyncratic hepatotoxicity, Crit. Rev. Toxicol., 35, 325, 10.1080/10408440590935620 · DOI · Paper page
  11. de Morais, 1992, Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome, Gastroenterology, 102, 577, 10.1016/0016-5085(92)90106-9 · DOI · Paper page
  12. Rubin, 2018, Acetaminophen-induced acute liver failure is more common and more severe in women, Clin. Gastroenterol. Hepatol., 16, 936, 10.1016/j.cgh.2017.11.042 · DOI
  13. Watkins, 2006, Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily, JAMA, 296, 87, 10.1001/jama.296.1.87 · DOI · Paper page
  14. Mak, 2018, Editor's highlight: an impaired immune tolerance animal model distinguishes the potential of troglitazone/pioglitazone and tolcapone/entacapone to cause IDILI, Toxicol. Sci., 161, 412, 10.1093/toxsci/kfx219 · DOI
  15. Jaeschke, 2014, Acetaminophen-induced liver injury: from animal models to humans, J. Clin. Transl. Hepatol., 2, 153
  16. McGill, 2012, The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation, J. Clin. Invest., 122, 1574, 10.1172/JCI59755 · DOI · Paper page
  17. Xie, 2015, Mitochondrial protein adducts formation and mitochondrial dysfunction during N-acetyl-m-aminophenol (AMAP)-induced hepatotoxicity in primary human hepatocytes, Toxicol. Appl. Pharmacol., 289, 213, 10.1016/j.taap.2015.09.022 · DOI
  18. Meyers, 1988, Acetaminophen-induced inhibition of hepatic mitochondrial respiration in mice, Toxicol. Appl. Pharmacol., 93, 378, 10.1016/0041-008X(88)90040-3 · DOI · Paper page
  19. Cover, 2005, Peroxynitrite-induced mitochondrial and endonuclease-mediated nuclear DNA damage in acetaminophen hepatotoxicity, J. Pharmacol. Exp. Ther., 315, 879, 10.1124/jpet.105.088898 · DOI · Paper page
  20. Du, 2017, Mitochondria-targeted antioxidant Mito-Tempo protects against acetaminophen hepatotoxicity, Arch. Toxicol., 91, 761, 10.1007/s00204-016-1692-0 · DOI · Paper page
  21. Jaeschke, 1990, Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol, J. Pharmacol. Exp. Ther., 255, 935, 10.1016/S0022-3565(25)23217-7 · DOI · Paper page
  22. Gunawan, 2006, c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity, Gastroenterology, 131, 165, 10.1053/j.gastro.2006.03.045 · DOI · Paper page
  23. Nakagawa, 2008, Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation, Gastroenterology, 135, 1311, 10.1053/j.gastro.2008.07.006 · DOI · Paper page
  24. Sharma, 2012, Critical role for mixed-lineage kinase 3 in acetaminophen-induced hepatotoxicity, Mol. Pharmacol., 82, 1001, 10.1124/mol.112.079863 · DOI
  25. Xie, 2015, Inhibitor of apoptosis signal-regulating kinase 1 protects against acetaminophen-induced liver injury, Toxicol. Appl. Pharmacol., 286, 1, 10.1016/j.taap.2015.03.019 · DOI
  26. Saito, 2010, c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity, Toxicol. Appl. Pharmacol., 246, 8, 10.1016/j.taap.2010.04.015 · DOI · Paper page
  27. Win, 2014, JNK interaction with Sab mediates ER stress induced inhibition of mitochondrial respiration and cell death, Cell Death Dis., 5, 10.1038/cddis.2013.522 · DOI · Paper page
  28. Cubero, 2016, Combined activities of JNK1 and JNK2 in hepatocytes protect against toxic liver injury, Gastroenterology, 150, 968, 10.1053/j.gastro.2015.12.019 · DOI
  29. Du, 2015, Pathophysiological significance of c-jun N-terminal kinase in acetaminophen hepatotoxicity, Expert Opin. Drug Metab. Toxicol., 11, 1769, 10.1517/17425255.2015.1071353 · DOI
  30. Li, 2014, The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury, Cell Death Dis., 5, 10.1038/cddis.2014.241 · DOI · Paper page
  31. Ramachandran, 2013, Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice, Hepatology, 58, 2099, 10.1002/hep.26547 · DOI · Paper page
  32. Zhang, 2014, Role of receptor interacting protein (RIP)1 on apoptosis-inducing factor-mediated necroptosis during acetaminophen-evoked acute liver failure in mice, Toxicol. Lett., 225, 445, 10.1016/j.toxlet.2014.01.005 · DOI
  33. Dara, 2015, Receptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis, Hepatology, 62, 1847, 10.1002/hep.27939 · DOI · Paper page
  34. Kon, 2004, Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes, Hepatology, 40, 1170, 10.1002/hep.20437 · DOI · Paper page
  35. Bajt, 2006, Nuclear translocation of endonuclease G and apoptosis-inducing factor during acetaminophen-induced liver cell injury, Toxicol. Sci., 94, 217, 10.1093/toxsci/kfl077 · DOI · Paper page
  36. Bajt, 2008, Mitochondrial Bax translocation accelerates DNA fragmentation and cell necrosis in a murine model of acetaminophen hepatotoxicity, J. Pharmacol. Exp. Ther., 324, 8, 10.1124/jpet.107.129445 · DOI · Paper page
  37. Gujral, 2002, Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis?, Toxicol. Sci., 67, 322, 10.1093/toxsci/67.2.322 · DOI · Paper page
  38. McGill, 2011, HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity, Hepatology, 53, 974, 10.1002/hep.24132 · DOI · Paper page
  39. Boxill, 1958, Comparative pharmacological and toxicological evaluation of N-acetyl-p-aminophenol, salicylamide, and acetylsalicylic acid, J. Am. Pharm. Assoc. Am. Pharm. Assoc., 47, 479, 10.1002/jps.3030470706 · doi:10.1002/jps.3030470706
  40. Boyd, 1966, Liver necrosis from paracetamol, Br. J. Pharmacol. Chemother., 26, 606, 10.1111/j.1476-5381.1966.tb01841.x · DOI · Paper page
  41. Eder, 1964, Chronic toxicity studies on phenacetin, N-Acetyl-p-Aminophenol (NAPA) and acetylsalicylic acid on cats, Acta Pharmacol. Toxicol., 21, 197, 10.1111/j.1600-0773.1964.tb01784.x · DOI
  42. Potter, 1974, Acetaminophen-induced hepatic necrosis V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters, Pharmacology, 12, 129, 10.1159/000136531 · DOI · Paper page
  43. McGill, 2012, Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity, Toxicol. Appl. Pharmacol., 264, 387, 10.1016/j.taap.2012.08.015 · DOI · Paper page
  44. Davis, 1975, Hepatic glutathione depletion and impaired bromosulphthalein clearance early after paracetamol overdose in man and the rat, Clin. Sci. Mol. Med., 49, 495
  45. Xie, 2014, Mechanisms of acetaminophen-induced cell death in primary human hepatocytes, Toxicol. Appl. Pharmacol., 279, 266, 10.1016/j.taap.2014.05.010 · DOI · Paper page
  46. James, 2001, Pediatric pharmacology research unit network, NICHD. Measurement of acetaminophen-protein adducts in children and adolescents with acetaminophen overdoses, J. Clin. Pharmacol., 41, 846, 10.1177/00912700122010744 · DOI
  47. McGill, 2014, Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome, Hepatology, 60, 1336, 10.1002/hep.27265 · DOI · Paper page
  48. Bhattacharyya, 2014, Targeted liquid chromatography–mass spectrometry analysis of serum acylcarnitines in acetaminophen toxicity in children, Biomark. Med, 8, 147, 10.2217/bmm.13.150 · DOI · Paper page
  49. Lutkewitte, 2018, Lipin deactivation after acetaminophen overdose causes phosphatidic acid accumulation in liver and plasma in mice and humans and enhances liver regeneration, Food Chem. Toxicol., 115, 273, 10.1016/j.fct.2018.03.014 · DOI
  50. Marques, 2012, Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure, Hepatology, 56, 1971, 10.1002/hep.25801 · DOI · Paper page
  51. Williams, 2014, Neutrophil activation during acetaminophen hepatotoxicity and repair in mice and humans, Toxicol. Appl. Pharmacol., 275, 122, 10.1016/j.taap.2014.01.004 · DOI · Paper page
  52. Ni, 2012, Activation of autophagy protects against acetaminophen-induced hepatotoxicity, Hepatology, 55, 222, 10.1002/hep.24690 · DOI · Paper page
  53. Ni, 2016, Removal of acetaminophen protein adducts by autophagy protects against acetaminophen-induced liver injury in mice, J. Hepatol., 65, 354, 10.1016/j.jhep.2016.04.025 · DOI · Paper page
  54. Du, 2015, Benzyl alcohol protects against acetaminophen hepatotoxicity by inhibiting cytochrome P450 enzymes but causes mitochondrial dysfunction and cell death at higher doses, Food Chem. Toxicol., 86, 253, 10.1016/j.fct.2015.10.016 · DOI
  55. Du, 2013, The gap junction inhibitor 2-aminoethoxy-diphenyl-borate protects against acetaminophen hepatotoxicity by inhibiting cytochrome P450 enzymes and c-jun N-terminal kinase activation, Toxicol. Appl. Pharmacol., 273, 484, 10.1016/j.taap.2013.09.010 · DOI
  56. Xie, 2013, Purinergic receptor antagonist A438079 protects against acetaminophen-induced liver injury by inhibiting P450 isoenzymes, not by inflammasome activation, Toxicol. Sci., 131, 325, 10.1093/toxsci/kfs283 · DOI
  57. Jaeschke, 2006, Role of caspases in acetaminophen-induced liver injury, Life Sci., 78, 1670, 10.1016/j.lfs.2005.07.003 · DOI
  58. Kelava, 2010, Influence of small doses of various drug vehicles on acetaminophen-induced liver injury, Can. J. Physiol. Pharmacol., 88, 960, 10.1139/Y10-065 · DOI
  59. Siegers, 1978, Antidotal effects of dimethyl sulphoxide against paracetamol-, bromobenzene-, and thioacetamide-induced hepatotoxicity, J. Pharm. Pharmacol., 30, 375, 10.1111/j.2042-7158.1978.tb13260.x · DOI
  60. Williams, 2014, Protection against acetaminophen-induced liver injury by allopurinol is dependent on aldehyde oxidase-mediated liver preconditioning, Toxicol. Appl. Pharmacol., 274, 417, 10.1016/j.taap.2013.12.003 · DOI
  61. Ni, 2012, Liver-specific loss of Atg5 causes persistent activation of Nrf2 and protects against acetaminophen-induced liver injury, Toxicol. Sci., 127, 438, 10.1093/toxsci/kfs133 · DOI · Paper page
  62. Williams, 2013, Fas receptor-deficient lpr mice are protected against acetaminophen hepatotoxicity due to higher glutathione synthesis and enhanced detoxification of oxidant stress, Food Chem. Toxicol., 58, 228, 10.1016/j.fct.2013.04.031 · DOI
  63. Liu, 2006, Neutrophil depletion protects against murine acetaminophen hepatotoxicity, Hepatology, 43, 1220, 10.1002/hep.21175 · DOI · Paper page
  64. Jaeschke, 2007, Neutrophil depletion protects against murine acetaminophen hepatotoxicity: another perspective, Hepatology, 45, 1588, 10.1002/hep.21549 · DOI
  65. Saito, 2010, Mechanism of protection by metallothionein against acetaminophen hepatotoxicity, Toxicol. Appl. Pharmacol., 242, 182, 10.1016/j.taap.2009.10.006 · DOI
  66. Harrill, 2009, Population-based discovery of toxicogenomics biomarkers for hepatotoxicity using a laboratory strain diversity panel, Toxicol. Sci., 110, 235, 10.1093/toxsci/kfp096 · DOI
  67. Nickel, 2015, Reversal of mitochondrial transhydrogenase causes oxidative stress in heart failure, Cell Metab., 22, 472, 10.1016/j.cmet.2015.07.008 · DOI · Paper page
  68. Bourdi, 2011, Mispairing C57BL/6 substrains of genetically engineered mice and wild-type controls can lead to confounding results as it did in studies of JNK2 in acetaminophen and concanavalin a liver injury, Chem. Res. Toxicol., 24, 794, 10.1021/tx200143x · DOI
  69. Duan, 2016, Differential susceptibility to acetaminophen-induced liver injury in sub-strains of C57BL/6 mice: 6N versus 6J, Food Chem. Toxicol., 98, 107, 10.1016/j.fct.2016.10.021 · DOI
  70. Yohe, 2006, Involvement of Toll-like receptor 4 in acetaminophen hepatotoxicity, Am. J. Physiol. Gastrointest. Liver Physiol., 290, 10.1152/ajpgi.00239.2005 · DOI
  71. Jaeschke, 2012, Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity, Liver Int., 32, 8, 10.1111/j.1478-3231.2011.02501.x · DOI · Paper page
  72. Woolbright, 2017, The impact of sterile inflammation in acute liver injury, J. Clin. Transl. Res., 3, 170
  73. Antoniades, 2012, Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans, Hepatology, 56, 735, 10.1002/hep.25657 · DOI · Paper page
  74. Weber, 2003, Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model, Crit. Rev. Toxicol., 33, 105, 10.1080/713611034 · DOI · Paper page
  75. Slater, 1966, Necrogenic action of carbon tetrachloride in the rat: a speculative mechanism based on activation, Nature, 209, 36, 10.1038/209036a0 · DOI · Paper page
  76. Knockaert, 2012, Carbon tetrachloride-mediated lipid peroxidation induces early mitochondrial alterations in mouse liver, Lab. Investig., 92, 396, 10.1038/labinvest.2011.193 · DOI
  77. Díaz Gómez, 1975, Species differences in carbon tetrachloride-induced hepatotoxicity: the role of CCl4 activation and of lipid peroxidation, Toxicol. Appl. Pharmacol., 34, 102, 10.1016/0041-008X(75)90179-9 · DOI
  78. Thrall, 2000, Comparative metabolism of carbon tetrachloride in rats, mice, and hamsters using gas uptake and PBPK modeling, J. Toxicol. Environ. Health A, 60, 531, 10.1080/00984100050082085 · DOI
  79. Teschke, 2018, Liver injury by carbon tetrachloride intoxication in 16 patients treated with forced ventilation to accelerate toxin removal via the lungs: a clinical report, Toxics, 6, 10.3390/toxics6020025 · DOI
  80. Castro, 1974, Prevention of carbon tetrachloride-induced necrosis by inhibitors of drug metabolism—further studies on their mechanism of action, Biochem. Pharmacol., 23, 295, 10.1016/0006-2952(74)90420-1 · DOI
  81. Randle, 2008, Investigation of the effect of a panel of model hepatotoxins on the Nrf2-Keap1 defence response pathway in CD-1 mice, Toxicology, 243, 249, 10.1016/j.tox.2007.10.011 · DOI
  82. Xu, 2008, The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis, Lab. Investig., 88, 1068, 10.1038/labinvest.2008.75 · DOI · Paper page
  83. McCracken, 2017, C57BL/6 substrains exhibit different responses to acute carbon tetrachloride exposure: implications for work involving transgenic mice, Gene Expr., 17, 187, 10.3727/105221617X695050 · DOI
  84. Tsukamoto, 2009, “Second Hit” models of alcoholic liver disease, Semin. Liver Dis., 29, 178, 10.1055/s-0029-1214373 · DOI
  85. Chiang, 2013, Adenosine 2A receptor antagonist prevented and reversed liver fibrosis in a mouse model of ethanol-exacerbated liver fibrosis, PLoS One, 8, 10.1371/journal.pone.0069114 · DOI
  86. Hall, 1991, Hepatic fibrosis and cirrhosis after chronic administration of alcohol and “low-dose” carbon tetrachloride vapor in the rat, Hepatology, 13, 815, 10.1016/0270-9139(91)90246-R · doi:10.1016/0270-9139(91)90246-r
  87. Kubota, 2013, A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice, Clin. Exp. Pharmacol. Physiol., 40, 422, 10.1111/1440-1681.12102 · DOI
  88. Hajovsky, 2012, Metabolism and toxicity of thioacetamide and thioacetamide S-oxide in rat hepatocytes, Chem. Res. Toxicol., 25, 1955, 10.1021/tx3002719 · DOI · Paper page
  89. Hunter, 1977, Thioacetamide-induced hepatic necrosis. I. Involvement of the mixed-function oxidase enzyme system, J. Pharmacol. Exp. Ther., 200, 439, 10.1016/S0022-3565(25)30789-5 · DOI · Paper page
  90. Kang, 2008, Role of CYP2E1 in thioacetamide-induced mouse hepatotoxicity, Toxicol. Appl. Pharmacol., 228, 295, 10.1016/j.taap.2007.11.010 · DOI
  91. Belinsky, 1985, Hepatotoxicity due to allyl alcohol in deermice depends on alcohol dehydrogenase, Hepatology, 5, 1179, 10.1002/hep.1840050619 · DOI
  92. Brodie, 1971, Possible mechanism of liver necrosis caused by aromatic organic compounds, Proc. Natl. Acad. Sci. U. S. A., 68, 160, 10.1073/pnas.68.1.160 · DOI · Paper page
  93. McGill, 2015, The role of the c-Jun N-terminal kinases 1/2 and receptor-interacting protein kinase 3 in furosemide-induced liver injury, Xenobiotica, 45, 442, 10.3109/00498254.2014.986250 · DOI
  94. Williams, 2007, The metabolism and toxicity of furosemide in the Wistar rat and CD-1 mouse: a chemical and biochemical definition of the toxicophore, J. Pharmacol. Exp. Ther., 322, 1208, 10.1124/jpet.107.125302 · DOI
  95. Jaeschke, 1987, The role of acrolein in allyl alcohol-induced lipid peroxidation and liver cell damage in mice, Biochem. Pharmacol., 36, 51, 10.1016/0006-2952(87)90381-9 · DOI
  96. Leist, 1995, Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models, Am. J. Pathol., 146, 1220
  97. Bechmann, 2008, Apoptosis versus necrosis rate as a predictor in acute liver failure following acetaminophen intoxication compared with acute-on-chronic liver failure, Liver Int., 28, 713, 10.1111/j.1478-3231.2007.01566.x · DOI
  98. Jaeschke, 2012, Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity, Drug Metab. Rev., 44, 88, 10.3109/03602532.2011.602688 · DOI · Paper page
  99. Ramachandran, 2018, Mitochondrial dysfunction as a mechanism of drug-induced hepatotoxicity: current understanding and future perspectives, J. Clin. Transl. Res.
  100. Leach, 1941, Sulfonamide drugs as protective agents against carbon tetrachloride poisoning, Exp. Biol. Med. (Maywood), 48, 361, 10.3181/00379727-48-13322P · DOI
  101. Roth, 1997, Is exposure to bacterial endotoxin a determinant of susceptibility to intoxication from xenobiotic agents?, Toxicol. Appl. Pharmacol., 147, 300, 10.1006/taap.1997.8301 · DOI · Paper page
  102. Dickes, 1957, Serial liver-function and blood studies in patients receiving chlorpromazine, N. Engl. J. Med., 256, 1, 10.1056/NEJM195701032560101 · doi:10.1056/nejm195701032560101
  103. Buchweitz, 2002, Underlying endotoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy?, J. Pharmacol. Exp. Ther., 300, 460, 10.1124/jpet.300.2.460 · DOI
  104. Deng, 2006, Modest inflammation enhances diclofenac hepatotoxicity in rats: role of neutrophils and bacterial translocation, J. Pharmacol. Exp. Ther., 319, 1191, 10.1124/jpet.106.110247 · DOI
  105. Dugan, 2010, A mouse model of severe halothane hepatitis based on human risk factors, J. Pharmacol. Exp. Ther., 333, 364, 10.1124/jpet.109.164541 · DOI
  106. Lu, 2012, Amiodarone exposure during modest inflammation induces idiosyncrasy-like liver injury in rats: role of tumor necrosis factor-alpha, Toxicol. Sci., 125, 126, 10.1093/toxsci/kfr266 · DOI
  107. Luyendyk, 2003, Ranitidine treatment during a modest inflammatory response precipitates idiosyncrasy-like liver injury in rats, J. Pharmacol. Exp. Ther., 307, 9, 10.1124/jpet.103.054288 · DOI
  108. Shaw, 2007, Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha, Toxicol. Sci., 100, 259, 10.1093/toxsci/kfm218 · DOI · Paper page
  109. Uetrecht, 2013, Idiosyncratic adverse drug reactions: current concepts, Pharmacol. Rev., 65, 779, 10.1124/pr.113.007450 · DOI · Paper page
  110. Mosedale, 2017, Drug-induced liver injury: advances in mechanistic understanding that will inform risk management, Clin. Pharmacol. Ther., 101, 469, 10.1002/cpt.564 · DOI · Paper page
  111. Maddox, 2010, Bacterial- and viral-induced inflammation increases sensitivity to acetaminophen hepatotoxicity, J. Toxicol. Environ. Health A, 73, 58, 10.1080/15287390903249057 · DOI
  112. Williams, 2010, Acetaminophen-induced hepatic neutrophil accumulation and inflammatory liver injury in CD18-deficient mice, Liver Int., 30, 1280, 10.1111/j.1478-3231.2010.02284.x · DOI
  113. Pastor Rojo, 2007, Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease, Inflamm. Bowel Dis., 13, 269, 10.1002/ibd.20019 · DOI · Paper page
  114. Metushi, 2015, Development of a novel mouse model of amodiaquine-induced liver injury with a delayed onset, J. Immunotoxicol., 12, 247, 10.3109/1547691X.2014.934977 · DOI
  115. Metushi, 2015, Treatment of PD-1 −/− mice with amodiaquine and anti-CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients, Hepatology, 61, 1332, 10.1002/hep.27549 · DOI · Paper page
  116. Ong, 2007, Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities, Toxicol. Sci., 97, 205, 10.1093/toxsci/kfl180 · DOI · Paper page
  117. Fujimoto, 2009, Sensitivity of liver injury in heterozygous Sod2 knockout mice treated with troglitazone or acetaminophen, Toxicol. Pathol., 37, 193, 10.1177/0192623308329282 · DOI
  118. Hsiao, 2010, Trovafloxacin, a fluoroquinolone antibiotic with hepatotoxic potential, causes mitochondrial peroxynitrite stress in a mouse model of underlying mitochondrial dysfunction, Chem. Biol. Interact., 188, 204, 10.1016/j.cbi.2010.07.017 · DOI
  119. Kashimshetty, 2009, Underlying mitochondrial dysfunction triggers flutamide-induced oxidative liver injury in a mouse model of idiosyncratic drug toxicity, Toxicol. Appl. Pharmacol., 238, 150, 10.1016/j.taap.2009.05.007 · DOI
  120. Ong, 2006, Nimesulide-induced hepatic mitochondrial injury in heterozygous Sod2+/− mice, Free Radic. Biol. Med., 40, 420, 10.1016/j.freeradbiomed.2005.08.038 · DOI
  121. Lucena, 2010, Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injury, Hepatology, 52, 303, 10.1002/hep.23668 · DOI
  122. Nicoletti, 2017, Gastroenterology, 152, 1078, 10.1053/j.gastro.2016.12.016 · DOI · Paper page
  123. McGill, 2018, Biomarkers of drug-induced liver injury: progress and utility in research, medicine, and regulation, Expert. Rev. Mol. Diagn., 10.1080/14737159.2018.1508998 · DOI
  124. Turpeinen, 2007, Predictive value of animal models for human cytochrome P450 (CYP)-mediated metabolism: a comparative study in vitro, Xenobiotica, 37, 1367, 10.1080/00498250701658312 · DOI
  125. Trepanier, 1997, Cytosolic arylamine N-acetyltransferase (NAT) deficiency in the dog and other canids due to an absence of NAT genes, Biochem. Pharmacol., 54, 73, 10.1016/S0006-2952(97)00140-8 · DOI
  126. Trepanier, 2004, Idiosyncratic toxicity associated with potentiated sulfonamides in the dog, J. Vet. Pharmacol. Ther., 27, 129, 10.1111/j.1365-2885.2004.00576.x · DOI
  127. Court, 2000, Molecular genetic basis for deficient acetaminophen glucuronidation by cats: UGT1A6 is a pseudogene, and evidence for reduced diversity of expressed hepatic UGT1A isoforms, Pharmacogenetics, 10, 355, 10.1097/00008571-200006000-00009 · DOI · Paper page

Cited by

See all 185

Metadata

Authors
McGill, M. R., & Jaeschke, H.
Venue
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Publisher
Elsevier BV
Published
2019-05
Volume
1865
Issue
5
Pages
1031-1039
ISSN
0925-4439
Cited by
185
References
6
Language
en
Funders
  • University of Arkansas for Medical Sciences
  • National Institutes of Health (R01 DK102142, P20 GM103549, P30 GM118247)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.